Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 27, 2021
Reporting Period: Specific event date of October 27, 2021.
Business Context: The company is an emerging growth company incorporated in British Columbia, Canada, with common shares traded on The Nasdaq Stock Market LLC under the symbol "INM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate governance event and does not contain financial statements or performance metrics.
Material Changes
Event Reported: On October 27, 2021, InMed Pharmaceuticals Inc. filed an Amended Notice of Meeting & Record Date relating to its 2021 annual meeting of shareholders on the System for Electronic Document Analysis and Retrieval ("SEDAR") in Canada.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the information provided, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section nor incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this text beyond the standard legal disclaimers regarding the status of the furnished information.
Investor Verification Checklist
- Verify the details of the Amended Notice of Meeting & Record Date by reviewing the SEDAR filing referenced as Exhibit 99.1.
- Confirm the specific record date and meeting logistics for the 2021 annual meeting of shareholders.
- Note that this 8-K does not contain financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.